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Abstract
Background: Post-operative morbidity affects up to 36% of cardiac surgical patients. However, few countries reliably
record morbidity outcome data, despite patients wanting to be informed of all the risks associated with surgery. The
Cardiac Post-Operative Morbidity Score (C-POMS) is a new tool for describing and scoring (0–13) total morbidity
burden after cardiac surgery, derived by noting the presence/absence of 13 morbidity domains on days 3, 5, 8 and 15.
Identifying modifiable C-POMS risk factors may suggest targets for intervention to reduce morbidity and healthcare
costs. Thus, we explored the association of C-POMS with previously identified predictors of post-operative morbidity.
Methods: A systematic literature review of pre-operative risk assessment models for post-operative morbidity was
conducted to identify variables associated with post-operative morbidity. The association of those variables with
C-POMS was explored in patients drawn from the original C-POMS study (n = 444).
Results: Seventy risk factors were identified, of which 56 were available in the study and 49 were suitable for analysis.
Numbers were too few to analyse associations on D15. Thirty-three (67.3%) and 20 (40.8%) variables were associated
with C-POMS on at least 1 or 2 days, respectively. Pre-operative albumin concentration, left ventricular ejection fraction
and New York Heart Association functional class were associated with C-POMS on all days. Of the 16 independent risk
factors, pre-operative albumin and haemoglobin concentrations and weight are potentially modifiable.
Conclusions: Different risk factors are associated with total morbidity burden on different post-operative days. Pre-
operative albumin and haemoglobin concentrations and weight were independently predictive of post-operative total
morbidity burden suggesting therapeutic interventions aimed at these might reduce both post-operative morbidity
risk and health-care costs in patients undergoing cardiac surgery.
Keywords: Risk factor, Cardiac surgery, Morbidity outcome, C-POMS
Background
In surgery, post-operative mortality is the most commonly
cited outcome variable and to date has been considered
the standard measure of quality of care. However, while
cardiac operative mortality has fallen (currently 2.1% in
the USA (Society of Thoracic Surgeons) and 1.5% in the
UK (Bridgewater et al. 2008)), post-operative morbidity re-
mains common affecting between 4.3% (Fortescue et al.
2001) and 36% (Magovern et al. 1996) of cardiac patients
and significantly prolonging length of stay (LOS) (Dupuis
et al. 2001). Such morbidity has substantial impact on
healthcare resources, with the average in-hospital
incremental cost of experiencing any complication at
$15,468 per patient (Brown et al. 2008). Thus, strategies to
identify and reduce post-operative morbidity might reduce
both patient well-being and healthcare costs.
However, few countries reliably record morbidity out-
come data (Weiser et al. 2008). Previously, morbidity
definitions included death (Fortescue et al. 2001),
focused on major morbid events only (Huijskes et al.
2003), or used surrogate markers of morbidity (for
example post-operative LOS (Magovern et al. 1996;
Dupuis et al. 2001)). Likewise, many national cardiac
surgical registers collect only 30-day mortality outcome
and in some cases hospital LOS. Contrastingly, although
the Society of Thoracic Surgeons national database
contains 49 variables related to post-operative events, a
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morbidity includes in-hospital death and only five severe
specific morbidities (Shahian et al. 2010).
The Cardiac Post-Operative Morbidity Score (C-
POMS) (Sanders et al. 2012) is a simple, validated score
(0–13) by which to identify and quantify total morbidity
burden (TMB) after adult cardiac surgery (Table 1) on
multiple post-operative days. We have previously re-
ported that every unit increase in C-POMS is associated
with a 1.7, 2.2 and 4.5-day increase in subsequent LOS
on days 3 (D3), 5 (D5) and 8 (D8) (Sanders et al. 2012),
which has significant associated health-care costs, organ-
isational and resource implications. Efforts to identify the
risk factors associated with this post-operative TMB score
may not only assist in identifying modifiable risk factors
for which therapeutic interventions can be implemented
to reduce the post-operative risk, but also serve to poten-
tially further validate C-POMS as a useful clinical tool in
cardiac surgery post-operative morbidity assessment.
Thus, we sought to identify risk factors associated with
post-operative TMB, as assessed by the C-POMS tool,
with an aim of identifying potentially modifiable risk
factors that could be therapeutic targets to reduce post-
operative cardiac surgical morbidity.
Methods
The National Research Ethics Committee London-
Bentham (Chair Professor David Katz) gave ethics
permission for this study (protocol amendment 7) on 6
September 2011 (reference 04/Q0502/73). All patients
included in this study gave written informed consent to
participate.
Participants
Patients were drawn from the development and validation
of the C-POMS study, detailed elsewhere (Sanders et al.
2012). In brief, patients undergoing any form of adult
cardiac surgery (excluding cardiac surgery for a congenital
heart condition or a cardiomyopathy) between January
2005 and November 2007 at the Heart Hospital,
University College London Hospitals NHS Trust, UK,
and who gave written informed consent were eligible
for inclusion. Excluded were those <18 years old,
undergoing emergency surgery, who were enrolled in
clinical intervention trials or who died within 5 days
of surgery.
C-POMS
The development and validation of the C-POMS tool
and score is detailed elsewhere (Sanders et al. 2012). In
brief, The McMaster Framework (Kirshner and Guyatt,
1985; Guyatt et al. 1992) for constructing and assessing
health indices for discriminative instruments, comprising
item selection, item scaling, item reduction and deter-
mination of reliability and validity processes, was used.
The C-POMS represents TMB as a summary score (0–13),
derived by noting the presence or absence of 13 morbidity
domains on days 3 (D3), 5 (D5), 8 (D8) and 15 (D15) after
cardiac surgery (Table 1).
Pre- and intra-operative clinical data
A protocol development group, comprising 15 represen-
tatives from cardiac nursing, surgery, intensive care and
anaesthesia, determined the pre-, intra-, and post-
operative variables to be collected prior to commence-
ment of the study. In brief, these included demographic
details, past and current medical history, coronary heart
disease risk factors, routine biochemistry and haematol-
ogy measurements, anaesthesia details, operative details
and a detailed record of the first 24 h in the intensive
care unit. Variables were either obtained from the
Society of Cardiothoracic Surgery national database or
prospectively from the medical and nursing records by a
dedicated, experienced research nurse using a standar-
dised proforma.
Identification and categorisation of potential risk factors
To identify pre-operative risk prediction models of post-
operative morbidity following cardiac surgery, a
systematic literature review was conducted using the
basic framework for conducting systematic reviews from
the Centre for Reviews and Dissemination (Dissemin-
ation Centre for Reviews and Dissemination 2001).
Three methodological quality filters were utilised. Firstly,
the study population was defined as an adult population
undergoing any form of cardiac surgery (excluding
transplantation and grown-up congenital heart surgery);
only methodologies that constructed a pre-operative risk
assessment tool were included; valid outcomes were
mortality and morbidity. There were no exclusions on
the basis of the definition of either outcome. Search
terms included cardiac surgery score, cardiac surgery
risk score, pre-operative risk; cardiac surgery and risk
prediction score; cardiac surgery, coronary artery bypass
graft (CABG), surgery morbidity and surgery outcome.
In addition to publication databases (the National
Centre for Biotechnology Information, Entrez retrieval
system and the Web of Science ISI Citation Databases),
sources of on-going and recently completed studies (The
National Research Register, The Cochrane Library of
Systematic Reviews) were also interrogated to identify
eligible papers. In total, the abstracts of 1067 papers
were scrutinised. Backward and forward citation
searches were conducted on all identified eligible papers.
Overall, a total of 21 pre-operative risk prediction
models were identified.
All pre- and intra-operative variables obtained within
the C-POMS study were classified with respect to these
models into one of two tiers (results in Additional file 1):
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Tier 1 variables were those which had been associated
with morbidity risk in three or more separate papers (sig-
nificant evidence), while tier 2 variables were those identi-
fied in one or two papers (some evidence).
Statistical methods
Baseline characteristics are presented as mean ± SD or
n (%). For the univariate analysis, C-POMS is
presented as the median score and compared over cat-
egories using the Kruskal-Wallis test. The association of
continuous variables with C-POMS was assessed using
the Spearman rank correlation. For the multivariate
analysis, variables with p < 0.25 on univariate analysis were
considered for inclusion into the models and stepwise
regression with backwards elimination and a threshold of
p < 0.05 was run. Validation of the models was performed
by running 1000 bootstrap samples. Variables selected in
at least 60% of the bootstrap samples were included in the
final model. For the data on all time points combined, the
models used were random intercept models with time fit-
ted as a fixed effect.
Results
Baseline participant characteristics
Of 748 potentially eligible patients undergoing cardiac
surgery, 520 (69.5%) were screened (due to researcher
availability) and 464 (89.2%) consented to participate.
Fourteen participants subsequently became ineligible,
leaving 450 who completed the study. Six participants
declined for their data to be used outside the develop-
ment of C-POMS.
Table 2 summarises participant characteristics. The
majority were White British (379, 85.4%), male (351,
79.1%) with a mean age of 66.6 years (range 19–91 years).
Most had triple vessel disease (243, 54.7%), a good
(>50%) left ventricular ejection fraction (LVEF) (323,
74.1%) and were of moderate mortality risk (mean
EuroSCORE 4.1). The majority had elective surgery
(69.6%), using cardiopulmonary bypass (412, 93.4%) and
stayed on intensive care unit (ICU) for an average of
2.0 days while remaining in the operating hospital for
Table 1 The Cardiac Post-Operative Morbidity Score (C-POMS)
(as reported in Sanders et al. 2012)
Morbidity type C-POMS criteria
Pulmonary Presence of one or more of the following:
▪ New requirement for oxygen or respiratory
support (including nebuliser therapy or request
for chest physiotherapy on or after D5)
▪ Pleural effusion requiring drainage
Infectious Presence of one or more of the following:
▪ Currently on antibiotics
▪ Has had a temperature of >38 °C in the last 24 h
▪ Has a white cell count/CRP level requiring
in-hospital review or treatment
Renal Presence of one or more of the following:
▪ Presence of decreased urine output requiring
intervention (including IV furosemide)
▪ Increased serum creatinine (>30% from
pre-operative level)
▪ Urinary catheter in situ
▪ New urinary incontinence
▪ Serum potassium abnormalities requiring treatment
Gastrointestinal Presence of one or more of the following:
▪ Unable to tolerate an enteral diet for any reason
including nausea, vomiting and abdominal
distension
▪ Nasogastric tube
▪ Diagnosis of a gastrointestinal bleed
▪ Diarrhoea
Cardiovascular Presence of one or more of the following:
▪ The use of inotropic therapy for any
cardiovascular cause
▪ Pacing wires (on or after D5)
and/or requiring temporary or new
permanent pacing
▪ Diagnostic tests or therapy within the last 24 h
for any of the following: (1) new MI or ischaemia,
(2) hypotension (requiring fluid therapy,
pharmacological therapy or omission of
pharmacological therapy, (3) atrial or ventricular
arrhythmias, (4) cardiogenic pulmonary oedema,
thrombotic event (requiring anticoagulation),
(5) hypertension (pharmacological therapy
or omission of pharmacological therapy)
Neurological New neurological deficit (including confusion, delirium,
coma, lack of coordination, drowsy/slow to wake,
poor swallow, blurred vision, sedated, changing
loss of consciousness)
Haematological Presence of one or more of the following:
▪ Untherapeutic INR requiring pharmacological
therapy or omission of pharmacological therapy
▪ Requirement for any of the following within the
last 24 h: packed erythrocytes, platelets,
fresh-frozen plasma, or cryoprecipitate
Wound Presence of one or more of the following:
▪ Wound dehiscence requiring surgical exploration
or drainage of pus from the operation wound with
or without isolation of organisms
▪ Chest drains
▪ Wound pain significant enough to require
continuing or escalating analgesic intervention
Pain Postoperative pain significant enough to require
parenteral opioids and/or continuing or additional
analgesia
Endocrine New or additional requirements for blood sugar
management
Table 1 The Cardiac Post-Operative Morbidity Score (C-POMS)
(as reported in Sanders et al. 2012) (Continued)
Electrolyte Electrolyte (including sodium, urea, phosphate)
imbalance requiring oral or intravenous
intervention (not including potassium as included
in renal category)
Review Remaining in hospital for further review, investigation
and/or procedure
Assisted
ambulation
A new or escalated post-operative requirement
for mobility assistance (including wheelchair,
crutches, zimmer frame, walking sticks or assistance)
CRP C-reactive protein, IV intravenous, MI myocardial infarction, INR international
normalised ratio, OPA out-patient appointment, OT occupational therapy
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9.5 days. The observed in-hospital mortality rate was
1.3%. Overall, 444 (100.0%) were in-patients on D1 and
D3, 420 (94.6%) on D5, 178 (40.1%) on D8 and 45
(10.1%) on D15. Subsequent risk factor analysis was only
appropriate on D3, D5 and D8 due to low numbers on
D15.
Tier 1 and 2 analysis
Univariate analysis Fifty-six variables were identified in
tiers 1 and 2. The incidence of seven (12.5%) pre-
operative variables (cardiogenic shock, catheter-induced
coronary closure, intra-aortic balloon pump, intubation,
permanent pacemaker, immunosuppressant medications
and inotropes) was too small for analysis, resulting in 49
variables (23 tier 1; 26 tier 2) for analysis. Thirty-three of
the 49 (67.3%) variables previously identified to be asso-
ciated with post-operative morbidity were found to be
associated with C-POMS on at least one post-operative
day (Table 3). Of those, 10 variables were associated with
C-POMS summary score on 1 day only, on either D3
(smoking, body mass index, urgency of operation, use of
cardiopulmonary bypass, total drainage within the first
12 h and D1 inotropes) or D5 (ethnicity, neurological
history, pre-operative heart rate and dialysis). No
variables were solely predictive of D8 C-POMS summary
score. Twenty variables (40.8%) were associated with C-
POMS summary score on 2 days, while 3 variables (pre-
operative albumin and New York Heart Association
(NYHA) class and LVEF) were associated with C-POMS
summary score on all days.
Overall, 8/23 (34.7%) tier 1 variables and 8/26 (34.7%)
tier 2 variables were not associated with C-POMS
summary score on any post-operative day (results in
Additional file 2).
Multivariate analysis Of the 49 variables, 16 (32.7%)
were independent risk factors of C-POMS summary
score on one or more post-operative days, while no vari-
ables were associated with C-POMS outcome on all
three post-operative days (Table 4).
There were eight tier 1 variables, all of which (with the
exception of renal dysfunction) were associated with
TMB on D3. Diabetes, LVEF, CABG surgery and renal
dysfunction were also associated with D5 C-POMS sum-
mary score. However, only tier 2 variables (pre-operative
Table 2 Baseline characteristics (n = 444). All values n (%) unless
otherwise stated
Frequency/mean ± SD
Demographics
Age (mean/years) 66.6 ± 10.7
Female gender 93 (20.9)
Ethnicity (White British) 379 (85.4)
Medical history
Renal (dialysis) 7 (1.6)
History of previous MI 148 (33.3)
Re-operation 18 (4.1)
Symptoms
NYHA Class
I 115 (26.0)
II 205 (46.3)
III 101 (22.8)
IV 22 (5.0)
Cardiac risk factors
Smoking
Current 49 (11.0)
Ex 245 (55.2)
Never 150 (33.8)
Hypertension 303 (68.2)
Hypercholesteraemia 343 (77.4)
Diabetes 103 (23.2)
Body mass index (kg/m2)/mean 28.5 ± 5.6
Examination and investigation
LVEF
Good 323 (74.1)
Fair 90 (20.6)
Poor 23 (5.3)
Pre-operative risk assessment
EuroSCORE 4.1 ± 2.8
Intra-operative details
Operative priority—elective 309 (69.6)
Operation performed
CABG 299 (67.3)
AVR 61 (13.7)
MVR 10 (2.3)
CABG + AVR 36 (8.1)
CABG + MVR 0 (0.0)
AVR + MVR 3 (0.7)
CABG + AVR + MVR 2 (0.5)
Other 33 (7.4)
Cardiopulmonary bypass used 412 (93.4)
Table 2 Baseline characteristics (n = 444). All values n (%) unless
otherwise stated (Continued)
Outcome
Length of ICU stay (mean/days) 2.0 ± 3.5
Return to theatre 21 (4.8)
Total length of hospital stay (mean/days) 11.8 ± 11.7
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Table 3 Univariate analysis: tier 1 and 2 predictors of C-POMS summary score on D3, D5 and D8
Variable D3 (n = 441) D5 (n = 419) D8 (n = 177)
Median
C-POMS/Rho
p Median
C-POMS/Rho
p Median
C-POMS/Rho
p
Tier 1 variables
Demographics
Age 0.188 0.000 0.110 0.025 0.133 0.078
Age quartiles
1 (0–59) 2.0 0.002 2.0 0.010 2.0 0.300
2 (60–68) 3.0 2.0 3.0
3 (69–74) 3.0 2.0 4.0
4 (≥75) 4.0 2.5 3.0
Age grp 2
<65 2.0 0.000 2.0 0.044 2.5 0.083
65–74 3.0 2.0 3.0
≥75 4.0 2.5 3.0
Age grp 3
<70 3.0 0.001 2.0 0.426 3.0 0.225
70–79 3.0 2.0 3.0
>80 5.0 2.0 3.0
Gender
M 3.0 0.024 2.0 0.016 3.0 0.215
F 3.0 3.0 2.5
Medical history
Diabetes
Y 4.0 0.000 2.5 0.015 3.0 0.308
N 3.0 2.0 3.0
Cerebrovascular disease
Y 4.0 0.028 3.0 0.023 4.0 0.219
N 3.0 2.0 3.0
Neurological history
Y 4.0 0.103 3.0 0.016 4.0 0.553
N 3.0 2.0 3.0
Congestive heart failure
Y 4.0 0.009 4.0 0.025 4.0 0.310
N 3.0 2.0 3.0
COPD/lung disease
Y 4.0 0.005 3.0 0.012 3.0 0.380
N 3.0 2.0 3.0
Renal disease
Y 5.0 0.064 5.0 0.001 5.0 0.025
N 3.0 2.0 3.0
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Table 3 Univariate analysis: tier 1 and 2 predictors of C-POMS summary score on D3, D5 and D8 (Continued)
POSSUM ECG
Normal 3.0 0.000 2.0 0.000 3.0 0.200
Sinus abnormal 5.0 4.0 –
AF 4.0 3.0 3.0
Any other abnormal 5.0 2.5 2.0
Paced
Y 5.0 0.005 4.0 0.014 2.5 0.875
N 3.0 2.0 3.0
Dialysis
Y 5.5 0.073 7.5 0.006 5.5 0.064
N 3.0 2.0 3.0
Pre-operative measurements
Body mass index(kg/m2) 0.100 0.043 0.077 0.130 0.099 0.206
LVEF
Good 3.0 0.013 2.0 0.011 3.0 0.013
Fair 3.0 2.0 4.0
Poor 5.0 5.0 4.0
Intra-operative
Type of surgery
CABG 3.0 0.000 2.0 0.000 3.0 0.718
AVR 4.0 3.0 3.0
MVR 5.0 3.0 3.5
CABG + AVR 4.0 2.0 3.0
AVR + MVR 3.0 3.0 4.5
CABG + MVR + AVR 5.0 5.0 6.0
Other 5.0 3.0 3.0
Urgency of op
Elective 3.0 0.002 2.0 0.061 3.0 0.327
Urgent 4.0 2.0 3.0
Within first 12 h
Systolic blood pressure (highest) 0.002 0.959 0.026 0.599 −0.089 0.238
Tier 2 variables
Demographics
Ethnicity
Caucasian 3.0 0.052 2.0 0.008 3.0 0.532
Asian 2.0 1.0 3.0
Black 5.0 3.0 3.0
Other 2.0 3.0 1.0
Medical history
Smoking
Current 2.0 0.048 2.0 0.395 3.0 0.753
Ex 3.0 2.0 3.0
Never 3.0 2.0 3.0
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Table 3 Univariate analysis: tier 1 and 2 predictors of C-POMS summary score on D3, D5 and D8 (Continued)
Family Hx CAD
Y 3.0 0.002 2.0 0.019 3.0 0.686
N 4.0 2.0 3.0
Atrial arrhythmia
Y 4.0 0.021 3.0 0.007 3.0 0.781
N 3.0 2.0 3.0
Pre-operative measurements
Albumin −0.210 0.000 −0.144 0.004 −0.183 0.019
Haemoglobin −0.279 0.000 −0.180 0.000 −0.143 0.058
Heart rate 0.090 0.058 0.179 0.000 0.080 0.294
Weight 0.044 0.369 0.042 0.399 0.101 0.186
No diseased vessels
0 4.0 0.011 3.0 0.000 3.0 0.203
1 3.0 2.0 2.0
2 3.0 2.0 2.0
3 3.0 2.0 3.0
NYHA class
1 2.0 0.001 1.0 0.002 3.0 0.001
2 3.0 2.0 3.0
3 4.0 3.0 3.0
4 5.0 2.5 5.0
CCSC class
0 3.0 0.041 3.0 0.042 3.0 0.317
1 2.0 2.0 2.0
2 3.0 2.0 3.0
3 3.0 2.0 3.0
4 4.0 2.0 4.0
Cardiomegaly
Y 5.0 0.000 3.0 0.000 4.0 0.141
N 3.0 3.0 3.0
Not stated 3.0 3.0 3.0
Extracardiacarteriopathy
Y 5.0 0.003 3.0 0.004 4.5 0.147
N 3.0 2.0 3.0
Current medications
Diuretic
Y 4.0 0.003 3.0 0.003 3.0 0.780
N 3.0 2.0 3.0
Intra-operative
Cardiopulmonary bypass
Y 3.0 0.001 2.0 0.072 3.0 0.098
N 2.0 1.0 1.0
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albumin, number of diseased vessels and number of sa-
phenous vein grafts) were independently predictive of D8
score and these variables were not independent risk fac-
tors for any other post-operative day. Pre-operative
haemoglobin, 12 h drainage, pre-operative weight and
extra cardiacarteriopathy were tier 2 risk factors associated
with D3 and D5 morbidity score, while pre-operative car-
diomegaly and NYHA class were associated with D5 score
only. Considering all time points, 12-h total drainage, pre-
operative weight, extra-cardiac arteriopathy, age, diabetes,
CABG surgery, pre-operative cardiomegaly and pre-
operative albumin level were independently predictive of
C-POMS-defined post-operative morbidity outcome.
Discussion
We found that over two thirds (67.3%) of variables,
previously reported as a risk factor for post-operative
morbidity, were associated with the new C-POMS (de-
noting TMB) on at least one post-operative day, with
40% being significant risk factors for two post-operative
days and three (6.1%) associated on all three post-
operative days. From these results, there are four main
findings of note. Firstly, we aimed to identify independent
modifiable C-POMS risk factors amenable to therapeutic
intervention. These were found to be pre-operative albu-
min and haemoglobin levels and weight—all tier 2 vari-
ables. Previously, pre-operative hypoalbuminaemia has
been identified as a risk factor for post-operative delirium
(Rudolph et al. 2009), reoperation for bleeding (Engelman
et al. 1999), requirement for renal replacement therapy
need (Engelman et al. 1999; Sato et al. 2015), increased
ICU and hospital LOS (Engelman et al. 1999; Koertzen et
al. 2013) and increased mortality (Engelman et al. 1999;
Koertzen et al. 2013) cardiac surgery. While hypoalbumi-
naemia may be directly harmful, it may also mark other
pathological states, such as anaemia, since pre-operative
hypoalbuminaemia and anaemia are independently
associated (Carrascal et al. 2010). Similarly, in cardiac
surgery, pre-operative anaemia is associated with in-
hospital (De Santo et al. 2009; Hung et al. 2011) or 30-day
(Boening et al. 2011) mortality, post-operative blood trans-
fusion rate (De Santo et al. 2009; Hung et al. 2011;
Boening et al. 2011), ICU (De Santo et al. 2009; Hung et
al. 2011) and in-hospital LOS (De Santo et al. 2009), major
adverse cardiovascular events (Boening et al. 2011), and
renal complications (De Santo et al. 2009; Boening et al.
2011) than non-anaemic patients. However, evidence re-
lating to whether pre-operative anaemia is associated with
infection (Boening et al. 2011) or not (De Santo et al.
2009) is conflicting. There is less evidence relating pre-
operative weight to post-operative outcome. Weight loss
after bariatric surgery improves hypertension, diabetes and
dyslipidaemia (Batsis et al. 2007), although unintended pre-
operative weight loss (≥10%) is also associated with
prolonged hospital LOS (van Venrooij et al. 2008). Evidence
of association is, of course, not the same as proof of caus-
ation. However, overall, taken with associated literature, our
findings suggest pre-operative albumin, haemoglobin and
weight to be candidates for pre-operative interventional
studies with the aim of improving post-operative morbidity.
Secondly, we identified 17 independent risk factors for
TMB on at least one post-operative day. Interestingly, except
for renal dysfunction, the other seven tier 1 variables were
all associated with D3 morbidity, with only three (diabetes,
LVEF and CABG surgery) also being associated on D5 and
none with D8 morbidity. Independent risk factors for D8
TMB lay entirely in tier 2. Such findings perhaps suggest
that different risk factors are associated with outcome on
different post-operative days and that well-accepted risk fac-
tors may only be useful for predicting morbidity risk in the
first few days of recovery. Patterns of morbidity are well-
recognised to differ with time after surgery, and it is likely
that their drivers (whether they be intrinsic, environmental,
or related to nascent morbidities) will also vary. Such factors
Table 3 Univariate analysis: tier 1 and 2 predictors of C-POMS summary score on D3, D5 and D8 (Continued)
Within 1st 12 h after surgery
Total drainage 0.139 0.004 0.030 0.542 0.031 0.679
Post-operative (D1)
Heart rhythm
Sinus rhythm 3.0 0.000 2.0 0.002 3.0 0.473
Sinus tachycardia 2.5 2.0 2.5
Sinus bradycardia 4.0 2.0 4.0
Atrial fibrillation 5.0 3.0 4.0
Other 3.0 2.0 3.0
Inotropes
Y 4.0 0.004 3.0 0.070 3.0 0.923
N 3.0 2.0 3.0
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are likely to explain the fact that correlations between D3
and D5 with D8 data differed. Furthermore, this study adds
to the evidence that pre-operative haemoglobin concentra-
tion, pre-operative weight, extra-cardiac arteriopathy, pre-
operative cardiomegaly, NYHA class, pre-operative albumin,
number of diseased vessels, and number of saphenous vein
grafts are independently associated with morbidity outcome.
Thirdly, as expected, the majority of tier 1 variables
(those with significant evidence of association with post-
operative morbidity) were associated with TMB on at
least one post-operative day. While this is not clinically
surprising, it does further validate C-POMS as a useful
clinical tool in outcome assessment following cardiac
surgery. In relation to the eight tier 1 variables that were
not associated with TMB on any post-operative day,
combining cerebrovascular accident and transient is-
chaemic attack to a combined cerebrovascular disease
variable was associated with a higher C-POMS on D3
and D5, in line with other morbidity risk assessment
models (Magovern et al. 1996; Huijskes et al. 2003;
Higgins et al. 1992; Tuman et al. 1992). Furthermore,
while hypertension has been independently associated
with post-operative morbidity in some studies (for ex-
ample, Fortescue et al. (2001) and Ivanov et al. (2006)),
this has been disputed by others (Higgins et al. 1992;
Hattler et al. 1994). However, our results pertaining to sys-
tolic blood pressure, previous cardiac surgery and diagnosed
peripheral vascular disease are at odds with the literature.
Finally, this study also adds to the more limited data
relating to some variables (those in tier 2) and their
association with post-operative morbidity after cardiac
surgery. Of these, 65.4% were associated with C-POMS
TMB score on at least one post-operative day, while pre-
operative albumin measurement and NYHA class were
risk factors for all three post-operative days. Further-
more, this study also confirmed the findings of previous
studies suggesting that unstable angina or recent myo-
cardial infarction (Tuman et al. 1992; Hattler et al. 1994)
and pre-existing liver disease (Higgins et al. 1992) are
not associated with post-operative morbidity. However,
while our study corroborated that of Magovern et al.
(Magovern et al. 1996) showing that pre-operative atrial
arrhythmia and cardiomegaly are associated with morbidity
outcome (Magovern et al. 1996), such results conflict with
those found by Hattler and colleagues (Hattler et al. 1994).
There are four main limitations of this study. Firstly,
there was no consistent definition of post-operative
morbidity used in the pre-operative risk assessment
models reported by others. Thus, a wide-range of vari-
ables to predict such diversely described outcomes were
identified. However, over two-thirds of all variables were
found to be associated with TMB, as defined by C-
POMS, on at least one post-operative day suggesting
that C-POMS is a valid measure of morbidity. Secondly,
from the pre-operative risk assessment models, it is diffi-
cult to assess what variables were not found to be associ-
ated with post-operative morbidity. Most studies did not
report variables for which no association with morbidity
was identified, due to the often large number (>100) of
variables included. We have made our statistically non-
significant results available to redress this balance and to
aid in the evaluation of this (and other) tools. Thirdly,
14 risk factors identified in the pre-operative risk assess-
ment models were available within this study dataset.
Some variables, such as transplantation and ventricular-
septal defect, were not available as these surgery types
were not included in the study, while the others were
non-routinely recorded items. Aside from catastrophic
states, the variables not included were all tier 2 variables
and in the main were only associated with outcome in
one previous study. Finally, analysis to identify risk
predictors for C-POMS TMB on D15 could not be con-
ducted due to there being too few participants remaining
in the hospital on D15 (n = 45). However, this could be
the subject of future work.
Conclusions
Post-operative morbidity is increasingly accepted as an inde-
pendent quality of care indicator, with approximately 80% of
patients wanting to be informed of all the risks associated
with surgery (Larobina et al. 2007). Thus, in obtaining op-
erative consent, patients should be told about ‘less serious
side effects and complications’ (General Medical Council
2008). C-POMS is a tool that permits such morbidity assess-
ment and TMB scoring at several time points after cardiac
surgery, allowing both broad and detailed tracking of mor-
bidities. We have found that pre-operative albumin, haemo-
globin and weight are potentially modifiable risk factors for
which the investigation of the effect of therapeutic interven-
tions on C-POMS outcome is warranted. Furthermore, we
have identified, for the first time, that risk factors differ for
different post-operative days. Further work should include
the identification of novel risk factors of C-POMS TMB
score for each post-operative day, and the identification of
risk factors associated with each C-POMS morbidity type to
identify the risk factors associated with D15 C-POMS sum-
mary score. Additionally, further validation of these results
could be sought in a subsequent C-POMS dataset. Such
identification of risk factors for C-POMS TMB may aid pa-
tient group and individual risk stratification and potentially
reduce healthcare costs.
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